際際滷

際際滷Share a Scribd company logo
Month Performance

uMx Khan.
Lahore, Pakistan.
Novartis-OTC Devision.
Overview
 Sales

Performance
 Sample Management
 KPI Performance
 Activities Execution
 BMD Review
 MAT
 Next Month Objectives & Planning
Sales Performance
Brands
CAC 1000 PLUS COLA 10
CAC 1000 PLUS COLA 20
CAC 1000 PLUS I.C 10
CAC 1000 PLUS ORANGE T10
CAC 1000 PLUS ORANGE T20
CAC 1000 PLUS PINEAPPLE 10
OPTALIDON TABS
QALSAN-D ORANGE 30
QALSAN-D TABS STRW 30
QALSAN-D TABS MIX 30
QALSAN-D TABS MNT 30
SANCOS
SPASMO CIBALGIN
T-DAY TABS
T-DAY SYRUP
VOLTRAL EMULGEL20G
VOLTRAL EMULGEL50G
LAMISIL CREAM
BENEFIBER 150 G
BENEFIBER SACHET S-10
BENEFIBER SACHET S-30
Total Value
CaC 1000 Plus
Qalsan-D
T Day
VEG
Lamisil
Benefiber

Target

Sep
Ach.

417
227
87
10,127
654
64
315
3,047
3,334
1,544
60
406
763
1,363
68
127
133
368
45

527
225
26
7,053
913
177
421
2,648
2,246
2,184
1,229
47
842
966
1,459
101
110
188
228
35

1,927,637
1,051,358
545,658
79,583
125,514
21,559
52,476

%age

YTD
Ach.

Target

126
99
30
70
140
275
133
87
67
141
#DIV/0!
#DIV/0!
79
208
127
107
149
87
142
62

%age

1,385
846
350
32,535
2,535
408
1,887
8,450
9,084
3,918
1,729
11,643
382
1,600
2,545
5,689
281
502
437
1,055

1,454
550
126
29,619
2,804
266
1,899
8,001
11,401
4,160
1,988
14,648
330
1,932
3,496
4,626
301
480
626
919

105
65
36
91
111
65
101
95
126
106
115
126
86
121
137
81
107
96
143
87

79

205

123

60

1,838,525
845,353
571,971
146,872
139,775
18,761

95
80
105
185
111
87

6,970,324
3,493,533
1,596,074
300,153
523,705
85,402

6,974,106
3,216,207
1,759,152
375,012
439,608
81,724

100
92
110
125
84
96

53,644

102

173,591

188,336

108
Target
1%
6%

5%

2% 2%

23%
61%

CaC Plus
Qalsan D
VEG
T.Day
Lamisil
Benefiber
Others
Achievement in %age
185

87 102

112
105
80%

Cac Plus
Qalsan D
VEG
T.Day
Lamisil
Benefiber
Others
Overall
1928

1579

1600
1400

1763

1200
1000
743

800

Target
Achievement
%

600
400
120%

200

4%

0
Total
SPLY
CaC Plus
1200
1000

1051

1086

824
770
686

800
600

Target
Achievement
%

475

400

120%

200

112%

316

109 290%

0
CaC
Plus

T10

T20

129%

SPLY
Qalsan D
571
300
250

545

214

200

Target
Achievement
%

129

150
100
50

105%

67%

0
Qalsan D
SPLY
VEG
140

139

132

120
100

92

125

76

80

Target
Achievement
%

60
40

40
111%

20
0
VEG

20g

107%
8

50g

48
149%

SPLY

111%
T.Day
90

145

81

80
70

80
58

60
50

45

Target
Achievement
%

43

40
30
2023

20

10

185%

208%

127%

0

T.Day

Tab

Syp

86%

SPLY
Lamisil
16

15

15

14
12

10

10
8

Target
Achievement
%

6

6
4

87%

137%

2
0
Lamisil
SPLY
Sample Management
Allocated

Executed

175

174

Qalsan D

100

80

T.Day

176

176

VEG

130

130

Cac Plus

Lamisil
KPI Performance
T V

U 1

2

3

A

45 45 0 0

2

10 28 5 100 115 16 149 171 20

B

70 67 3 0

62 8

0

0 96

85

136 116

C

45 24

0

0

0 53

53

45

21

24

0

4

5 C

F

A TV AV W

24
Activities Execution
Allocated

Operated

Rx

Cac Plus

4

4

35

VEG

2

2

22

T.Day

2

2

25

Lamisil

1

1

7

Total

9

9

93
Next Month Objectives & Planning
Achieve Monthly Budget and deficit.
 CaC Plus Budget.
 Osonate, Fastum Gel, Rigix Tab.
 Pace of Lamisil Cream.
 Meeting KPI.
 Resources Utilization.
 Activities Execution.
Thank You.

More Related Content

Sales Presentation